ATE205489T1 - N-substituierte azaheterocyclische carbonsäuren und ihre alkylester - Google Patents

N-substituierte azaheterocyclische carbonsäuren und ihre alkylester

Info

Publication number
ATE205489T1
ATE205489T1 AT96907326T AT96907326T ATE205489T1 AT E205489 T1 ATE205489 T1 AT E205489T1 AT 96907326 T AT96907326 T AT 96907326T AT 96907326 T AT96907326 T AT 96907326T AT E205489 T1 ATE205489 T1 AT E205489T1
Authority
AT
Austria
Prior art keywords
carboxylic acids
alkylesters
azaheterocyclic carboxylic
substituted azaheterocyclic
substituted
Prior art date
Application number
AT96907326T
Other languages
English (en)
Inventor
Tine Krogh Jorgensen
Knud Erik Andersen
Henrik Sune Andersen
Rolf Hohlweg
Peter Madsen
Uffe Bang Olsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE205489T1 publication Critical patent/ATE205489T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT96907326T 1995-04-07 1996-04-01 N-substituierte azaheterocyclische carbonsäuren und ihre alkylester ATE205489T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK40395 1995-04-07
DK100695 1995-09-11
PCT/DK1996/000138 WO1996031497A1 (en) 1995-04-07 1996-04-01 Novel heterocyclic compounds

Publications (1)

Publication Number Publication Date
ATE205489T1 true ATE205489T1 (de) 2001-09-15

Family

ID=26063927

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96907326T ATE205489T1 (de) 1995-04-07 1996-04-01 N-substituierte azaheterocyclische carbonsäuren und ihre alkylester

Country Status (9)

Country Link
US (5) US5698551A (de)
EP (1) EP0820450B1 (de)
JP (1) JPH11503126A (de)
AT (1) ATE205489T1 (de)
AU (1) AU5100296A (de)
CA (1) CA2217206A1 (de)
DE (1) DE69615169D1 (de)
IL (1) IL117816A0 (de)
WO (1) WO1996031497A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952352A (en) * 1995-04-07 1999-09-14 Novo Nordisk A/S Heterocyclic compounds
AR015446A1 (es) * 1997-09-19 2001-05-02 Smithkline Beecham Corp Antagonistas de receptores de vitronectina, composicion farmaceutica que los contiene, procedimiento para su preparacion, su uso para la elaboracion de unmedicamento y compuestos intermediarios
US6576643B2 (en) 1997-09-19 2003-06-10 Smithkline Beecham Corporation Vitronectin receptor antagonists
US6214816B1 (en) 1998-03-17 2001-04-10 Novo Nordisk A/S Heterocyclic compounds
JP2002506863A (ja) * 1998-03-17 2002-03-05 ノボ ノルディスク アクティーゼルスカブ 新規ヘテロ環式化合物
US6705675B1 (en) * 2000-05-08 2004-03-16 Graco Children's Products Inc. Adjustable child seat for toddlers to small children
US20040220167A1 (en) * 2003-05-02 2004-11-04 Nasrollah Samiy Methods of treating neuralgic pain
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
TW200615273A (en) * 2004-11-10 2006-05-16 Nicholas Piramal India Ltd Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
WO2006053273A2 (en) * 2004-11-12 2006-05-18 Alcon, Inc. Optical fiber detection method and system

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1084267B (de) * 1955-12-28 1960-06-30 Cilag Chemie Verfahren zur Herstellung von 1-Aza-[2, 3:5, 6]-dibenzocycloheptadien-derivaten, deren Salzen und quaternaeren Ammoniumverbindungen
US2861987A (en) * 1955-12-28 1958-11-25 Cilag Ltd New diphenyl methane- and 1-aza-[2,3:5,6]-dibenzocy cloheptadiene derivatives, theiracid salts and quaternary salts and the production thereof
FR145F (de) * 1964-06-01
US3336293A (en) * 1964-11-06 1967-08-15 Searle & Co Complex amides of 5, 6-dihydrophenanthridine-5-carboxylic acid, 5, 6-dihydro-11h-dibenz[b, e]azepine-5-carboxylic acid, and related compounds
US3514443A (en) * 1965-01-22 1970-05-26 Squibb & Sons Inc 5-(substituted amino-lower alkylene)-5,6-dihydrodibenz(b,f)azocines
US3803143A (en) * 1969-09-08 1974-04-09 Eisai Co Ltd 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines
JPS57106673A (en) * 1980-12-24 1982-07-02 Chugai Pharmaceut Co Ltd Dibenzo(b,f)(1,4)oxazepin derivative
GB2094790B (en) * 1981-03-13 1985-10-09 Spofa Vereinigte Pharma Werke Tricycle compounds
FR2512024A1 (fr) * 1981-08-27 1983-03-04 Adir Ethers tricycliques, leur preparation et les compositions pharmaceutiques les contenant
EP0332246A1 (de) * 1988-03-11 1989-09-13 Akzo N.V. Trizyklische Amin-Derivate
DK93791D0 (da) * 1991-05-17 1991-05-17 Novo Nordisk As Nye heterocykliske carboxylsyrer
GB9120640D0 (en) * 1991-09-27 1991-11-06 Ici Plc Tricyclic heterocycles
US5354747A (en) * 1993-06-16 1994-10-11 G. D. Searle & Co. 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use
MY113463A (en) * 1994-01-04 2002-03-30 Novo Nordisk As Novel heterocyclic compounds
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands

Also Published As

Publication number Publication date
JPH11503126A (ja) 1999-03-23
EP0820450B1 (de) 2001-09-12
US5750518A (en) 1998-05-12
AU5100296A (en) 1996-10-23
IL117816A0 (en) 1996-08-04
US5747481A (en) 1998-05-05
US5780486A (en) 1998-07-14
CA2217206A1 (en) 1996-10-10
US5846968A (en) 1998-12-08
DE69615169D1 (de) 2001-10-18
EP0820450A1 (de) 1998-01-28
WO1996031497A1 (en) 1996-10-10
US5698551A (en) 1997-12-16

Similar Documents

Publication Publication Date Title
DK0738262T3 (da) Hidtil ukendte heterocykliske forbindelser
MX9707531A (es) Nuevos compuestos heterociclicos.
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
PT1311285E (pt) Composicao farmaceutica liquida contendo um derivado de eritropoietina
EE200100485A (et) Uudsed ühendid ja kompositsioonid proteaasi inhibiitoritena
DK1039895T3 (da) Anvendelse af 3-benzoylphenyleddikesyrer, estere eller amider til behandling af GLC1A-glaukom
ATE205489T1 (de) N-substituierte azaheterocyclische carbonsäuren und ihre alkylester
PT1023267E (pt) Compostos de piridilo e composicoes farmaceuticas que os contem
BR0211604A (pt) Inibidores de integrina para o tratamento de doenças do olho
ES2173858T3 (es) Analogos de huperzina a.
EA200400708A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
BR0109328A (pt) Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica
DE69513837D1 (de) Cyklopeptolide
EA200400707A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
IL117811A0 (en) N-substituted azaheterocyclic carboxylic compounds their preparation and pharmaceutical compositions containing them
BG88028A (bg) Амиди на циклометилен-1,2-дикарбоксилни киселини с терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат
IL117812A0 (en) N-substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
ATE293591T1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide